Testing Teplizumab against a placebo for type 1 diabetes mellitus
Explore this study →
One site, in Halifax
Official title: A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Type 1 Diabetes Mellitus · Sanofi